glp-1 and osteoporosis weight loss drug study finds small increase in risk of gout The Impact of GLP1 Agonists

Skip the missed dose and continue your normal schedule

This suggests tirzepatide's receptor activity on muscle and joint tissue does not inherently trigger inflammation or pain the way some other medications do

Researchers analyzed the findings of 13 studies involving more than 1,100 people who had conditions that commonly cause fatigue, such as heart failure, autoimmune disorders, and cancer

While ertugliflozin did not outperform placebo for MACE, it significantly reduced hospitalizations for HF by 30% (59)

Your provider will work with you to safely titrate your medication based on your progress and how your body responds